Tag: Syngene IPO
-
Syngene Post IPO report
Post IPO report dated 17th Aug 2015 Dear Investor, Here is a short post listing report on the Syngene International IPO. The IPO that was open from 27-29th July received excellent response with a 32.05 times over-subscription. While Retail was only 4.8 times oversubscribed, the QIB portion was over 51.5 times and non institutional investors (NII) category…
-
Syngene IPO: Good Pharma R&D spinoff from Biocon
Date – 27th July 2015 Issue Price range: Rs. 240-250 and Issue Period: 27-29th July 2015 Target Market Cap Rs 5,000 crore and Industry – Pharma R&D First day – 32% subscribed Advice: Buy for 2-3 years The Syngene IPO is a first time offer from the high potential sector of pharma R&D Outsourcing. The Income, EBITDA…
JainMatrix Investments 